Research and Studies

Scientific Research regarding the role of omega-3 and vitamin E

 

A case series “Syndrome of Allergy, Apraxia, and Malabsorption: Characterization of a Neurodevelopmental Phenotype that Responds to Omega 3 and Vitamin E Supplementation” published in the July/August 2009 edition of Alternative Therapies in Health and Medicine represents the most comprehensive summary of children with apraxia to date.

 

Data from the case series show that 97% of families reported dramatic improvements in their children when taking this unique combination of ingredients. 

 

The study reported that…

“Oxidative stress and inflammation consume antioxidants and micronutrients, leaving less available to counterbalance oxidative stress over time.”1

 

“Use of high-dose PUFA and vitamin E in children with a history of VA appeared to lead to rapid clinical improvement of many symptoms of this neurological condition in a large cohort.”

 

1  Morris, Claudia R, and Agin, Marilyn C. Syndrome of Allergy, Apraxia, and Malabsorption: Characterization of a Neurodevelopmental Phenotype that Responds to Omega 3 and Vitamin E Supplementation. Alternative Therapies in health and Medicine 2009; Vol. 15, No. 4: 32-41.

 

The Oxford-Durham Schools Trials

Abstract

Background. Developmental coordination disorder (DCD) affects ∼5% of school-aged children. In addition to the core deficits in motor function, this condition is associated commonly with difficulties in learning, behavior, and psychosocial adjustment that persist into adulthood. Mounting evidence suggests that a relative lack of certain polyunsaturated fatty acids may contribute to related neurodevelopmental and psychiatric disorders such as dyslexia and attention-deficit/hyperactivity disorder. Given the current lack of effective, evidence-based treatment options for DCD, the use of fatty acid supplements merits investigation.

Methods. A randomized, controlled trial of dietary supplementation with ω-3 and ω-6 fatty acids, compared with placebo, was conducted with 117 children with DCD (5–12 years of age). Treatment for 3 months in parallel groups was followed by a 1-way crossover from placebo to active treatment for an additional 3 months.

Results. No effect of treatment on motor skills was apparent, but significant improvements for active treatment versus placebo were found in reading, spelling, and behavior over 3 months of treatment in parallel groups. After the crossover, similar changes were seen in the placebo-active group, whereas children continuing with active treatment maintained or improved their progress.

Conclusions. Fatty acid supplementation may offer a safe efficacious treatment option for educational and behavioral problems among children with DCD. Additional work is needed to investigate whether our inability to detect any improvement in motor skills reflects the measures used and to assess the durability of treatment effects on behavior and academic progress.

   Richardson, Alexandra and Montgomery, Paul. The Oxford-Durham Study: a Randomized, Controlled Trial of Dietary Supplementation with Fatty Acids in Children with Developmental Coordination Disorder. Pediatrics 2005; Vol. 1, No. 5: 1360-1366.